SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-042159
Filing Date
2018-06-26
Accepted
2018-06-26 08:30:21
Documents
4
Period of Report
2018-06-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-16033_18k.htm 8-K 22740
2 EX-99.1 a18-16033_1ex99d1.htm EX-99.1 73545
3 GRAPHIC g160331mmi001.jpg GRAPHIC 7436
4 GRAPHIC g160331mmi002.jpg GRAPHIC 16018
  Complete submission text file 0001104659-18-042159.txt   129954
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35619 | Film No.: 18918321
SIC: 2834 Pharmaceutical Preparations